Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtech Nervous About 'Sharing' Organizations Touted In US FDA Cyber Guidance

This article was originally published in SRA

Executive Summary

Medtech industry lobbyists say US Food and Drug Administration's recommendation for companies to join information sharing and analysis organizations (ISAOs) when dealing with cybersecurity issues is ambiguous and could have serious legal ramifications. Besides asking for clarification about what constitutes an ISAO, industry groups are calling for the agency to give companies more leeway to deal with potential cybersecurity vulnerabilities.

Advertisement

Related Content

'Sharing' Organizations Stay In Final Post-Market Cybersecurity Guidance
Advertisement
UsernamePublicRestriction

Register

MT040784

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel